ARROWHEAD PHARMACEUTICALS, INC. (ARWR) Total assets 2016–2025
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) total assets at each fiscal year-end, per SEC filings.
$1.4BFY2025 · since FY2016: $128.2M → $1.4B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.4B | +21.5% |
| FY2024 | $1.1B | +48.9% |
| FY2023 | $765.6M | +10.6% |
| FY2022 | $691.9M | -2.6% |
| FY2021 | $710.1M | +35.9% |
| FY2020 | $522.5M | +49.4% |
| FY2019 | $349.8M | +213.5% |
| FY2018 | $111.6M | +7.3% |
| FY2017 | $104.0M | -18.8% |
| FY2016 | $128.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ARWR financial trends
ARWR RevenueARWR Net incomeARWR Net marginARWR Gross profitARWR Gross marginARWR Operating incomeARWR Operating marginARWR Operating cash flowARWR Free cash flowARWR Capital expendituresARWR Return on equityARWR Stock buybacksARWR Dividends paidARWR Total liabilitiesARWR Shareholders’ equityARWR overview →